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ABSTRACT 
QSAR is the study of quantitative relationships between biological activity and the physicochemical properties of a common parent 
structure molecule. CS chemoffice software utilized for QSAR of series. The reported IC50 values were converted to negative log 
IC50 values, which were correlated with various descriptors. Upon stepwise, multiple, and sequential regression analysis of 
descriptor, the statistically significant QSAR equations were obtained. The correlation between the physicochemical parameters and 
the biological activity were found using the least squares method. The equations having good correlation coefficient (r2), F-test 
value, SD values and minimum variance were validated by the cross validation method and IC50 and pIC50 values were calculated 
using Valstat. 5-Benzenesulphonamido-1,3,4-thiadiazol-2-sulphonamide, was designed as parent structure.  
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INTRODUCTION: 
With the evolution of mankind, its confrontation with 
newer and complex diseases has also been increased. 
Humanity has always been searching for new ways to 
overcome the disease, and one of such way is the 
discovery of the newer drugs for the prophylaxis and/or 
treating the diseases. Today medicinal chemistry has 
been trying to reduce the toxicity and increases the 
therapeutic efficacy of the existing compound by 
structural modification using computer aided drug 
design and QSAR
1
. In the early 1960s, one could expect 
to discover a marketable compound out of 2000-3000 
tested molecules, where-as this ratio in now close to 1 in 
10000 and biological testing expenses have increased 
dramatically. Good drug must be replaced by better one, 
which often seemed to result from a small change in 
structure of the original or “lead” compound2. Drug 
design is inherently multi-disciplinary and involves the 
integration of vast amount of complex information, so 
computational methods can aid in this process. The 
strategy use in the design of drugs, involved a change in 
shape such that the new drug had a better ‘fit’ for 
receptor. Other strategies involved the change in the 
physical properties of the drug such that its distribution, 
metabolism, or receptor binding interactions were 
affected
3
.  
The primary objective of the research is to increase the 
efficiency by designing new drug by making structural 
modification with the help of QSAR & CADD where the 
chemical feature of molecules or series of molecules 
have been correlate to biological activities
4
.  
MATERIALS AND METHODS: 
The workstation 
All the computational studies were performed using 
software CS Chem. Office (Version 6.0).  
QSAR analysis of 2,5-disubstituted 1,3,4-thiadiazole 
QSAR analysis was carried out on all thirty compounds 
which are reported previously [5]. 
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Figure 1: Structure of Sulphonamide and 1,3,4-
Thiadiazole Derivatives which are reported as Carbonic 
Anhydrase Inhibitors are as follows 
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Upon stepwise, multiple, and sequential regression 
analysis of descriptor, the following statistically 
significant QSAR equations were obtained as follows. 
The correlation between the physicochemical parameters 
and the biological activity were found using the least 
squares method. The cross correlation matrix for –log 
IC50 and the various physicochemical descriptors were 
calculated for equation (1, 2, and 3).  
 BA = [5.31643(± 0.468307)] + HLC [0.300503(± 
0.103401)] + LUMO [-0.701809(± 0.384675)] + 
VDWE [0.083507(± 0.0521942)]  …..Equation (1) 
N = 30, r = 0.918647, r^2 = 0.843912, variance = 
0.103995, std = 0.322482, F = 46.8575 
 BA = [5.31042(± 0.418884)] + HLC [0.287537(± 
0.0929893)] + LUMO [-0.703293(± 0.34406)] + 
VDWE [0.086354(± 0.0467316) …..Equation (2) 
N = 29, r = 0.931009, r^2 = 0.866778, variance 
=0.0828709, std = 0.287873, F = 54.219 
 BA = [5.43547( ± 0.477882)] +DM [0.0686359( ± 
0.0675143)] +PMIY [7.44461e-005( ± 5.29802e-
005)] +NVDWE [-0.144571( ± 0.0782467)] 
+LUMO [-1.06437( ± 0.376148)] …..Equation (3) 
N = 30, r = 0.904767, r^2 = 0.818604, variance = 
0.125691, std = 0.354529, F = 28.2049  
Out of the several models, equation (2) was selecting as 
the best equation on considering the criteria for QSAR 
equations. The equation had better statistical 
significance viz., r > 0.8, std. deviation (std) should be 
minimum, statistically significant F value and the 
correlation matrix was found to be in the limit. 
Although the above equations are having good 
correlation coefficient (r
2
), sequential fisher test value 
(F-test) and standard deviation (Std) values and 
minimum variance. But in equation (3) shows less 
correlation than in equation (2). Equations (1, 2, and 3) 
were validated by the cross validation method and IC50 
and pIC50 values were calculated for these equations 
using software Valstat. The pIC50 calculated and 
predicted for the equations (1, 2, and 3) by Valstat are 
covered in the Table 1. Equations (1, 2, and 3) are 
validated by using different parameters such as cross-
validated correlation coefficient, predicted sum of 
squares, and standard error of prediction and cross-
validated equations are reported in the Table 2. 
 
Table 1: Predicted Activity Data of Earlier Synthesized Compounds 
Compd. 
No. IC50* 
Equation (1) Equation (2) Equation (3) 
pIC 50** 
Cal. 
pIC50 ** 
Pred. 
pIC50** 
Calc. 
pIC50 ** 
Pred. 
pIC 50** 
Cal. 
pIC50 ** 
Pred. 
(Ia) 3.228892 7.65354 7.67835 7.61418 7.63532 7.51513 7.53411 
(Ib) 2.656621 6.62968 6.64967 6.60267 6.61773 6.41428 6.39318 
(Ic) 2.734382 6.83843 6.84394 6.80039 6.80293 6.82511 6.83221 
(Id) 2.756201 6.83114 6.83419 6.79324 6.79301 6.82664 6.82997 
(Ie) 1.930475 6.95766 6.98075 6.92539 6.94687 6.62471 6.62666 
(If) 1.737577 6.9574 6.96279 6.92513 6.92846 6.62468 6.59319 
(Ig) 1.95221 6.93711 6.95869 6.90509 6.92483 6.61923 6.61737 
(Ih) 1.953405 6.90713 6.92897 6.87545 6.89504 6.61699 6.61371 
(Ii) 1.951018 6.97728 6.99903 6.94487 6.9654 6.69369 6.70419 
(Ij) 1.588046 6.69372 6.69668 6.66516 6.66461 6.73768 6.74897 
(Ik) 1.610167 6.71378 6.72227 6.68507 6.6904 6.7148 6.72738 
(Il) 1.440459 6.981 6.96894 6.94855 6.93426 6.79528 6.76165 
(Im) 1.271854 6.85372 6.53771 6.82119 6.47087 7.33379 7.60966 
(In) 1.652787 7.12452 7.10433 7.09076 7.06773 7.07325 7.0487 
(Io) 1.762105 8.035 8.13625 7.98791 8.0725 8.44837 8.57969 
(Ip) 0.889326 7.30917 7.35963 7.27296 7.32215 7.40561 7.46131 
(Iq) 1.25642 7.34023 7.4013 7.29577 7.35054 7.3543 7.45399 
(IIa) 1.278754 7.01245 7.00672 6.97175 6.96356 7.22887 7.24159 
(IIb) 2.440922 7.06207 7.02058 7.06207 7.02058 7.55027 7.39195 
(IIc) 1.66227 7.31066 7.31070 7.2739 7.27228 7.16904 7.15532 
(IId) 1.771029 7.26035 7.24107 7.21692 7.19093 7.46718 7.47505 
(IIe) 1.963489 7.23979 7.17812 7.19688 7.12543 7.53781 7.53395 
(IIf) 2.344829 7.52942 7.48820 7.48955 7.44369 7.74769 7.7162 
(IIg) 2.25329 8.1305 8.20568 8.08186 8.1297 8.387 8.54984 
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(IIh) 2.134695 6.95684 6.94726 6.91702 6.90466 7.73489 8.00052 
(IIi) 2.476107 8.5579 8.56907 8.57619 8.59324 8.10879 8.07261 
(IIIa) 2.698101 8.86932 8.83303 8.88264 8.85001 8.52344 8.45435 
(IIIb) 2.698101 8.90283 8.87316 8.91858 8.89367 8.56855 8.49718 
(IIIc) 2.298853 9.03929 9.16298 9.0572 9.1877 8.75267 8.76483 
(IIId) 2.476107 8.10072 8.04244 8.09029 8.03088 8.31289 8.08426 
IC50 =Biological activity, pIC50 = Negative log of IC50 value, *   Determined from systat, ** Determined from validated model in 
valstat, Cal. = Calculated, Pred. = Predicted 
 
RESULTS AND DISCUSSION: 
The study of Equation (2) revealed that thermodynamic 
(HLC, VDWE) and electronic (LUMO) parameters are 
associates with anticonvulsant activity. The HLC and 
VDWE contributed positively where as LUMO 
contributed negatively to biological activity. The 
equation suggested that HLC of molecule and VDWE 
are of significance, they are having better correlation 
with biological activity and have minimum standard 
deviation. The results shows overall significance level 
better than 99.9% as it exceeded the tabulated F value 
(54.219,F3,15). The Equation (3) revealed that all three 
parameters viz., thermodynamic (NVDWE), spatial 
(PMIY) and electronic (DM, LUMO) are associated 
with anticonvulsant activity.  The PMIY and DM have 
better correlation with biological activity and have low 
value of standard deviation. The data showed overall 
significant level greater than a 99.9% as it exceeded the 
tabulated F value (28.2049F3.15). Both of above 
equation was validated by leave one out cross validation 
method and bootstrapping method which give 
statistically significant values of internal equation where 
as Q^2 was found to be greater than 0.5 also statistically 
significant.
 
Table 2: Cross Validation with Different Parameters 
Sr. No. Parameters 
Equations 
20 21 22 
1 Q^2 0.766858 0.806632 0.719494 
2 SPRESS 0.394122 0.363346 0.440867 
3 SDEP 0.366908 0.337359 0.402455 
Q^2 : Cross validated correlation coefficient21, SPRESS : Predicted sum of squares, SDEP : standard error of prediction 
This statistical parameter represents a high level of 
significance having high Q^2 values (0.719494). PMIY 
is depends on the total mass of molecule, mass 
distribution within molecule and position of the axis of 
rotation of the molecule equation shows direct 
relationship between PMIY of molecule and biological 
activity, whereas DM is an indication of strength and 
orientation behavior in electrostatic field and shows 
direct correlation. NVDWE and LUMO energy is 
directly correlated to stability of molecule. 
CONCLUSION: 
On the basis of QSAR study and nucleus present in the 
reported series, the parent structure was selected. In 
the series; compounds (Ia-q, IIa-i, IIIa-d), 1,3,4-
thiadiazole, benzene and sulphonamide moieties are 
present and thus, 5-benzenesulphonamido-1,3,4-
thiadiazol-2-sulphonamide (IV), was selected as parent 
structure which contains all three aforesaid moieties.  
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On the basis of results and discussion theiron, the parent 
structure (IV) 1,3,4-thiadiazole will substituted at 
different position as represented R1, R2 and X .The 
bulkier substitution at R1 and electronegative group at 
R2 will play a significant role. However, X can be either 
hydrogen or acetyl group.  
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